Cargando…
Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy
Metachromatic leukodystrophy is a lethal metabolic leukodystrophy, with emerging treatments for early disease stages. Biomarkers to measure disease activity are required for clinical assessment and treatment follow-up. This retrospective study compared neurofilament light chain and glial fibrillary...
Autores principales: | Beerepoot, Shanice, Heijst, Hans, Roos, Birthe, Wamelink, Mirjam M C, Boelens, Jaap Jan, Lindemans, Caroline A, van Hasselt, Peter M, Jacobs, Edwin H, van der Knaap, Marjo S, Teunissen, Charlotte E, Wolf, Nicole I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967093/ https://www.ncbi.nlm.nih.gov/pubmed/34398223 http://dx.doi.org/10.1093/brain/awab304 |
Ejemplares similares
-
Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
por: Beerepoot, Shanice, et al.
Publicado: (2019) -
Metachromatic leukodystrophy and transplantation: remyelination, no cross‐correction
por: Wolf, Nicole I., et al.
Publicado: (2020) -
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy
por: Al‐Saady, Murtadha, et al.
Publicado: (2023) -
Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients
por: Beerepoot, Shanice, et al.
Publicado: (2020) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018)